BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 3077281)

  • 1. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM; Wood MJ
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target.
    James PA; Reeves DS
    J Chemother; 1996 Feb; 8 Suppl 2():37-47. PubMed ID: 8738845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cephalosporins: bacterial resistance measured by penicillin-binding proteins].
    Garrido J; López F
    Rev Med Chil; 1989 Sep; 117(9):1037-43. PubMed ID: 2519470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting of the penicillin binding proteins that are the target for inhibition by beta-lactams as a likely mechanism of resistance to antibiotics during therapy.
    Satta G; Canepari P; Maurici R; Pompei R; Marcialis MA
    Chemioterapia; 1985 Feb; 4(1):113-5. PubMed ID: 3986940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
    Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S
    J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin-binding proteins and peptidoglycan peptide-interacting proteins.
    Rodríguez-Tébar A; Vázquez D
    Microbiol Sci; 1984 Dec; 1(9):211-4. PubMed ID: 6444131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
    Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
    Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
    Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacylation kinetics analysis of Streptococcus pneumoniae penicillin-binding protein 2x mutants resistant to beta-lactam antibiotics using electrospray ionization- mass spectrometry.
    Di Guilmi AM; Mouz N; Pétillot Y; Forest E; Dideberg O; Vernet T
    Anal Biochem; 2000 Sep; 284(2):240-6. PubMed ID: 10964406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.